Scoop: Star neuroscientist Asa Abeliovich and OrbiMed are teaming on yet another biotech
It’s been barely a year since Eli Lilly bought his second company, Prevail Therapeutics, for $1 billion, but star Columbia neuroscientist Asa Abeliovich is already launching something new.
Two jobs were posted on LinkedIn last week for Leal Therapeutics, each recruiting scientists to a “CNS-focused biotech start-up working to develop a pipeline of novel, ultra-precise therapeutics for major CNS indications with urgent unmet needs.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.